Preclinical Drug Safety Analysis by Chemogenomic Profiling in the Liver

Author： Fielden Mark R.   Pearson Cecelia   Brennan Richard   Kolaja Kyle L.  

Publisher： Adis International

ISSN： 1175-2203

Source： American Journal of PharmacoGenomics, Vol.5, Iss.3, 2005-01, pp. : 161-171

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Capitalizing on Chemogenomic Concepts: Preclinical Safety Analysis to Help Develop Drugs, Not ‘Duds’

By Adis International Limited  

Pharmaceutical & Diagnostic Innovation, Vol. 3, Iss. 5, 2005-01 ,pp. : 3-7

Adis International

Access to resources Recommend Favorite

Thematic Analysis™ : A Chemogenomic Approach to GPCR Drug Discovery

By  

Current Topics in Medicinal Chemistry, Vol. 11, Iss. 15, 2011-08 ,pp. : 1925-1943

Bentham Science Publishers

Access to resources Recommend Favorite

Bringing Kinases Into Focus: Efficient Drug Design Through the Use of Chemogenomic Toolkits

By  

Current Medicinal Chemistry, Vol. 13, Iss. 15, 2006-06 ,pp. : 1735-1748

Bentham Science Publishers

Access to resources Recommend Favorite

Preclinical Investigation of the Safety of Eplir

By Saratikov A.   Livshits N.   Burchenkova F.   Kadychagova N.   Novozheeva T.   Akhmedzhanov R.   Perevozchikova T.   Bashirova L.  

Pharmaceutical Chemistry Journal, Vol. 39, Iss. 2, 2005-02 ,pp. : 64-66

Springer Publishing Company

Access to resources Recommend Favorite

Application of Pharmacogenomics in Drug Discovery and Development:Correlations Between Transcriptional Modulation and Preclinical Safety Observations

By  

Drug Metabolism Letters, Vol. 1, Iss. 1, 2007-01 ,pp. : 41-48

Bentham Science Publishers

Access to resources Recommend Favorite